ID 原文 译文
1097 ⑤涉及体位变动时进行气囊压力监测、冷凝水处理（双人配合倾倒，倒入预置含氯消毒液的加盖容器中）、气囊上分泌物处理； ⑤ Monitor the airbag pressure and deal with water condensates when the position changes (two people cooperate in dumping and pouring the water condensates into a capped container containing a pre-made disinfectant chlorine solution); deal with secretions accumulated in the airbag;
1098 ⑥及时清理患者口鼻分泌物。 ⑥ Clean up secretions from the mouth and nose timely.
1099 7）撤机拔管时机和策略 (7) Weaning of Ventilation
1100 当患者PaO2/FiO2>150mmHg时，可积极减停镇静剂唤醒，条件允许尽早拔管；采用HFNC或NIV进行拔管后的续贯呼吸支持。 Sedatives is reduced and discontinued before awakening when the patient’s PaO2/FiO2 is more than 150 mmHg. Intubation withdrawal should be performed as earlier as possible if permitted. HFNC or NIV is used for sequential respiratory support after withdrawal.
1101 八. 抗继发感染合理使用抗菌药物 VIII. The Rational Use of Antibiotics to Prevent Secondary Infection
1102 COVID-19是病毒感染性疾病，轻型及普通型患者不建议预防性使用抗菌药物； COVID-19 is a disease of viral infection, therefore antibiotics are not recommended to prevent bacterial infection in mild or ordinary patients;
1103 重型患者需要结合具体情况谨慎决定是否预防性使用抗菌药物， it should be used carefully in severe patients based on their conditions.
1104 对于病变范围广、气道分泌物多、原有慢性气道疾病伴下呼吸道病原体定植史、使用糖皮质激素（按泼尼松计）≥20mg×7d等情况的患者可考虑酌情使用抗菌药物，可选药物包括喹诺酮类、第二或第三代头孢菌素、β-内酰胺酶抑制剂复方制剂等； Antibiotics can be used with discretion in patients who have the following conditions: extensive lung lesions; excess bronchial secretions; chronic airway diseases with a history of pathogen colonization in the lower Respiratory tract; taking glucocorticoids with a dosage ≥ 20 mg × 7d (in terms of prednisone). The options of antibiotics include quinolones, the second or third generation cephalothins, β-lactamase inhibitor compounds, etc.
1105 危重型患者，尤其是接受有创机械通气的患者可考虑预防性使用抗菌药物， The antibiotics should be used for the prevention of bacterial infection in critically severe patients, especially those with invasive mechanical ventilation.
1106 根据患者个体高危因素选择抗菌药物，包括碳青霉烯类、β-内酰胺酶抑制剂复方制剂、利奈唑胺、万古霉素。 The antibiotics such as carbapenems, β-lactamase inhibitor compounds, linezolid and vancomycin can be used in critically ill patients according to the individual risk factors.